Harnessing the Reactivity of Sulfinate Salts With Cystine: An Umpolung Approach to Residue‐Specific Peptide Modification

J Joshua M. Hammond (Research School of Chemistry Australian National University Canberra Australia) E Esteban Suárez‐Picado (Research School of Chemistry Australian National University Canberra Australia) L Lena von Sydow H Hanna Bruss (Medicinal Chemistry Cardiovascular Renal and Metabolism (CVRM) Discovery Sciences BioPharmaceuticals R&D AstraZeneca Gothenburg Sweden) L Laurent Knerr (Medicinal Chemistry Cardiovascular Renal and Metabolism (CVRM) Discovery Sciences BioPharmaceuticals R&D AstraZeneca Gothenburg Sweden) M Magnus Johansson (Department of Cell & Molecular Biology, Uppsala University) A Anaïs Noisier (Medicinal Chemistry Cardiovascular Renal and Metabolism (CVRM) Discovery Sciences BioPharmaceuticals R&D AstraZeneca Gothenburg Sweden) L Lara R. Malins (Research School of Chemistry, Australian National University)

Abstract

ABSTRACT The first use of sulfinate salts for the late‐stage modification of peptidic disulfide bonds is reported. While the majority of cysteine‐based peptide modifications rely on the nucleophilicity of the side chain thiol functionality, umpolung approaches—exploiting instead the electrophilicity of the cystine disulfide—are underexplored. Using structurally diverse sulfinate salts, we have optimized a mild, photochemical strategy for the generation and coupling of carbon‐centered radicals with both symmetrical and electronically‐distinct, unsymmetrical cystine disulfides using high‐throughput experimentation techniques. A library of modified peptides was accessible, as confirmed by qualitative and quantitative analytical data, providing valuable insights into the matched reactivity of specific radical/disulfide substrate pairings. The method was broadly compatible with a range of unprotected amino acids, including histidine, tryptophan, and tyrosine, and can be used for the functionalization of biologically relevant peptides, as exemplified by the selective, late‐stage modification of a semaglutide analogue and the preparation of high‐value macrocyclic peptides.

Article Details

Volume / Issue Vol. 1, Issue 1
Published July 07, 2026
ISSN 1433-7851
Publisher Wiley

Journal Info

Angewandte Chemie International Edition

Wiley

ISSN: 1433-7851 Physical Sciences

Authors (8)

J

Joshua M. Hammond

Research School of Chemistry Australian National University Canberra Australia

E

Esteban Suárez‐Picado

Research School of Chemistry Australian National University Canberra Australia

L

Lena von Sydow

H

Hanna Bruss

Medicinal Chemistry Cardiovascular Renal and Metabolism (CVRM) Discovery Sciences BioPharmaceuticals R&D AstraZeneca Gothenburg Sweden

L

Laurent Knerr

Medicinal Chemistry Cardiovascular Renal and Metabolism (CVRM) Discovery Sciences BioPharmaceuticals R&D AstraZeneca Gothenburg Sweden

M

Magnus Johansson

Department of Cell & Molecular Biology, Uppsala University

A

Anaïs Noisier

Medicinal Chemistry Cardiovascular Renal and Metabolism (CVRM) Discovery Sciences BioPharmaceuticals R&D AstraZeneca Gothenburg Sweden

L

Lara R. Malins

Research School of Chemistry, Australian National University